Prof. Dr. med.
Alain Schoepfer
Médecin chef, CHUV
Swiss GastroTalk: Treat-to-Target with live Q&A
Quickfacts
- November 10, 2026
- 18:00–19:30
- Online Webinar (live Q&A)
- English
- Gastroenterology
Welcome to the Swiss GastroTalk Live Q&A!
Following our successful webcast on "Treat-to-Target," we are exited to invite you to this interactive follow-up session.
To get the most out of this live discussion, we highly recommend watching the 1-hour webcast recording in our library before joining us. Clinical practice is dynamic, and complex patient cases often raise practical questions that go beyond standard guidelines. This is your opportunity to bring those specific clinical challenges and real-world scenarios directly to our expert panel. Whether you want to dive deeper into the webcast topics or discuss new case management strategies, your questions will drive our live conversation. Participation is free, but registration is required, secure your spot today to receive your access link and join the conversation!
Introduction with patient cases
- Case 1 – Crohn’s disease (CD)
- Case 2 – Ulcerative Colitis (UC)
- Why Treat-to-Target? Development of treatment targets in CD, UC
Brief overview of
- Clinical remission vs. biomarker remission vs. endoscopic healing.
Treat-to-Target Concept
- Definition and rationale, treatment targets according to STRIDE II/III (Symptom control, normalisation of CRP/Calprotectin, endoscopic remission, transmural healing).
Monitoring & Diagnosing Strategies
- How do we monitor Treat-to-Target? Endoscopy, biomarkers, imaging (intestinal ultrasound, MRI enterography). How do we diagnose?
- How do we monitor deep remission? (peak–trough variability)
Clinical Decision Making
- Based on the topics discussed beforehand.
Future of Treat-to-Target
- Early intervention, top-down strategies, Biomarker-guided therapy, AI-assisted imaging.
Experts
Prof. Dr. med.
Prof. Dr. med. Dr. h. c.
Stefan Schreiber
Universitätsklinikum Schleswig-Holstein
